Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial (Q33521023)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial |
scientific article |
Statements
1 reference
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial (English)
1 reference
Jean-Yves Douillard
1 reference
Frances A Shepherd
1 reference
Vera Hirsh
1 reference
Mark A Socinski
1 reference
Radj Gervais
1 reference
Mei-Lin Liao
1 reference
Helge Bischoff
1 reference
Martin Reck
1 reference
Mark V Sellers
1 reference
Claire L Watkins
1 reference
Georgina Speake
1 reference
Alison A Armour
1 reference
Edward S Kim
1 reference
28 December 2009
1 reference
1 reference
Identifiers
1 reference